Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael Powell currently holds 2,914,776 shares of Entasis Therapeutics Holdings Inc. (ETTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Powell has been a net seller of ETTX stock. They have purchased $40.6M and sold $84.0M worth of shares.
Michael Powell's most recent insider trade was on May 18, 2021, when they purchased 727,272 shares at $11.00 per share.
Michael Powell serves as Executive at Entasis Therapeutics Holdings Inc. (ETTX). They have executed 109 insider transactions totaling $124.6M over their tenure at the company.
Michael Powell holds the position of Executive at Entasis Therapeutics Holdings Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Michael Powell has shown a selling trading pattern, with $40.6M in total purchases and $84.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Michael Powell was on Jul 9, 2014, when they sold $24.0M worth of AERI shares. This transaction involved 1,000,000 shares at $24.00 per share.
Michael Powell currently owns 2,914,776 shares of Entasis Therapeutics Holdings Inc. (ETTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael Powell's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael Powell has 109 Form 4 filings on record as an insider at Entasis Therapeutics Holdings Inc..
Set alerts for Michael Powell and 40,000+ other insiders.